Norepinephrine Bitartrate Injection USP 4 mg/4 mL recall: Sterility Concern
Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva…
Why was Norepinephrine Bitartrate Injection USP 4 mg/4 mL recalled?
Lack of Assurance of Sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # 100020800, exp 07/2022
- Product
- Norepinephrine Bitartrate Injection USP 4 mg/4 mL (1 mg/mL), 4 mL Single-Dose Vials, 10 vials per carton, Rx Only, Manufactured By: Teva…
- Recalling firm
- Teva Pharmaceuticals USA
- Quantity
- 11,450 vials
- Distribution
- Methylprednisolone, TN Norepinephrine BItartrate - MS, OH
- Recall date
- January 19, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)